http://purl.uniprot.org/citations/25426560 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/25426560 | http://www.w3.org/2000/01/rdf-schema#comment | "Although the combination of etoposide (VP16) and cisplatin (DDP) is widely used as a first-line treatment for advanced-stage small-cell lung cancer (SCLC), chemoresistance limits its clinical use. Abnormalities of autophagy are associated with tumor chemoresistance. The present study found that miR-24-3p, a recently discovered microRNA, is significantly downregulated in VP16-DDP-resistant SCLC cells (H446/EP) compared with VP16-DDP-sensitive parent cells (H446). Forced expression of miR-24-3p sensitized H446/EP cells to VP16-DDP treatment because of a blockade of autophagic activity. We further found that downregulated miR-24-3p enhanced autophagy activation as it directly targets and inhibits autophagy-associated gene 4A (ATG4A). Overexpression of miR-24-3p into H446/EP cells led to reduction of the ATG4A protein level, allowing SCLC cells to resensitize to VP16-DDP. We conclude that miR-24-3p regulates autophagy by targeting ATG4A. Inhibition of autophagy by increasing miR-24-3p could be the basis of a strategy to prevent and treat SCLC with combination chemotherapy, particularly in chemoresistant disease."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.org/dc/terms/identifier | "doi:10.18632/oncotarget.2787"xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Chen L."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Chen Y."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Song H."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Xu Y."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Wang R."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/author | "Pan B."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/date | "2015"xsd:gYear |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/name | "Oncotarget"xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/pages | "317-331"xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/title | "Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A."xsd:string |
http://purl.uniprot.org/citations/25426560 | http://purl.uniprot.org/core/volume | "6"xsd:string |
http://purl.uniprot.org/citations/25426560 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/25426560 |
http://purl.uniprot.org/citations/25426560 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/25426560 |
http://purl.uniprot.org/uniprot/#_B4DEA4-mappedCitation-25426560 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25426560 |
http://purl.uniprot.org/uniprot/#_G5E979-mappedCitation-25426560 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25426560 |
http://purl.uniprot.org/uniprot/#_Q8WYN0-mappedCitation-25426560 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25426560 |
http://purl.uniprot.org/uniprot/Q8WYN0 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25426560 |
http://purl.uniprot.org/uniprot/B4DEA4 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25426560 |
http://purl.uniprot.org/uniprot/G5E979 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25426560 |